DNA Renewal Infusion Regenerative repair for texture, hydration & skin quality
Its ability to support wound healing, improve skin quality, promote angiogenesis, and influence gene expression repair has made it a significant compound across both aesthetic and therapeutic research contexts
GLP-1 receptor agonists blunt drug-evoked dopamine release in the nucleus accumbens, and they do so across drugs that share no common pharmacology: cocaine, amphetamine, nicotine, alcohol, and fentanyl (Herman et al., 2026)
These functions are especially important under conditions of energetic stress, where metabolic flexibility is vital for cellular survival and function
What it means for private plans For employer plan sponsors, the report frames GLP-1 receptor agonists as a category where unit-price reductions from generics may be offset by: Higher patient volumes as access expands [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] New indications added to existing molecules [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] New, longer-acting and oral GLP-1 entrants in development [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Patients tracking coverage developments can review the generic semaglutide tracker, the insurance coverage checker, and the FAQ for additional context on Canadian pricing and plan rules